| 1461 |
National Cancer Institute |
Html |
en |
Vaginal Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of vaginal cancer. |
| ongoing clinical trials | 0.85552 |
| long time span | 0.761526 |
| vaginal carcinoma | 0.951107 |
| vaginal wall involvement | 0.883409 |
| prior hysterectomy | 0.778571 |
| vaginal cancer | 0.818887 |
| vaginal cancer. | 0.807751 |
| available staging tests | 0.778942 |
| upper vaginal lesions | 0.893311 |
| Regional lymph nodes | 0.757227 |
| concurrent chemotherapy | 0.764946 |
| clear cell carcinomas | 0.789213 |
| cervical cancer | 0.899035 |
| Vaginal adenosis | 0.826312 |
| vaginal carcinomas | 0.846251 |
| vaginal SCC patients | 0.90084 |
| treatment approaches | 0.767338 |
| women | 0.767592 |
| treatment | 0.85362 |
| AJCC staging system. | 0.759072 |
| vaginal vault | 0.831513 |
| case series | 0.90433 |
| utero DES exposure | 0.803909 |
| apical vagina | 0.754218 |
| vaginal intraepithelial neoplasia | 0.874302 |
|
| external-beam radiation | 0.754266 |
| treatment planning | 0.776769 |
| clear cell carcinoma | 0.966645 |
| clear cell adenocarcinoma | 0.790722 |
| vaginal cancers | 0.837225 |
| local modality therapies | 0.783604 |
| cervical cancer management | 0.790278 |
| noninvasive squamous cell | 0.774465 |
| relative efficacy | 0.761447 |
| Gy tumor dose | 0.754907 |
| vaginal clear cell | 0.868627 |
| disease | 0.778359 |
| precise staging criteria | 0.772344 |
| local control | 0.818953 |
| utero exposure | 0.878366 |
| Early stage tumors | 0.815533 |
| cervical intraepithelial neoplasia | 0.792254 |
| small case series | 0.758482 |
| insufficient dose penetration | 0.75402 |
| American Joint Committee | 0.782817 |
| locally advanced tumors | 0.766917 |
| Cervical Cancer Treatment | 0.817322 |
| surgical treatment options | 0.788171 |
| standard treatment | 0.795403 |
|
CLICK HERE |
| 1792 |
National Cancer Institute |
Html |
es |
Náuseas y vómitos relacionados con el tratamiento del cáncer (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca de las náuseas y vómitos como complicaciones del cáncer o su tratamiento. Se plantean abordajes de tratamiento de las náuseas y vómitos. |
| radioterapia nombre | 0.366149 |
| Dexametasona Corticosteroides | 0.345517 |
| palonosetrón antagonistas | 0.420992 |
| siguientes tipos | 0.357417 |
| siguientes estrategias | 0.348254 |
| único signo | 0.33198 |
| causa náuseas | 0.753796 |
| National Cancer Institute | 0.339057 |
| determinados medicamentos | 0.5578 |
| siguientes riesgos | 0.330997 |
| quimioterapia nombre | 0.555099 |
| PDQ Acupuntura | 0.392476 |
| Instituto Nacional | 0.371538 |
|
| siguientes problemas | 0.372583 |
| siguientes factores | 0.44966 |
| Physician Data Query | 0.449355 |
| Lorazepam Benzodiazepinas | 0.337793 |
| vómitos tardÃos | 0.949937 |
| siguientes caracterÃsticas | 0.461706 |
| determinadas situaciones | 0.34995 |
| fosaprepitant antagonistas | 0.342662 |
| prometazina fenotiacinas | 0.421253 |
| PDQ Náuseas | 0.567745 |
| medicamento tipo | 0.522815 |
| flujo sanguÃneo escaso | 0.412994 |
| haloperidol butirofenonas | 0.346571 |
|
CLICK HERE |
| 2012 |
National Cancer Institute |
Html |
es |
Exámenes de detección del cáncer de pulmón (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar o vigilar el cáncer de pulmón. |
| PDQ Exámenes | 0.778524 |
| Physician Data Query | 0.91448 |
| mayores probabilidades | 0.586703 |
| Estados Unidos | 0.865536 |
| rayos x | 0.605899 |
| prevención revisa | 0.573952 |
| PDQ Prevención | 0.807908 |
| siguientes exámenes | 0.801099 |
| principal causa | 0.623129 |
|
| información ayuda | 0.574441 |
| vÃas respiratorias | 0.622976 |
| National Cancer Institute | 0.606892 |
| siguientes riesgos | 0.571899 |
| PDQ Aspectos | 0.723454 |
| siguientes sumarios | 0.714394 |
| Lung Screening Trial | 0.688089 |
| Instituto Nacional | 0.689164 |
|
CLICK HERE |
| 2018 |
National Cancer Institute |
Html |
es |
Prevención del cáncer de pulmón (PDQ®)–Versión para profesionales de salud |
Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de pulmón y sobre las investigaciones dirigidas a la prevención de esta enfermedad. |
| agentes carcinógenos | 0.462163 |
| factores alimentarios | 0.825457 |
| Retinol Efficacy Trial | 0.359125 |
| Cancer Research Fund | 0.363502 |
| how much | 0.341238 |
| Pinsky PF | 0.34171 |
| Sin embargo | 0.481037 |
| largo plazo | 0.406049 |
| tasas anuales promedio | 0.375764 |
| Health Care Policy | 0.356657 |
| PDQ Consumo | 0.41794 |
| vitaminas antioxidantes e | 0.352553 |
| vitamina e | 0.340093 |
| Outcomes Prevention Evaluation | 0.355777 |
| estudio atbc | 0.383777 |
| Estados Unidos | 0.918409 |
| Natl Cancer Inst | 0.379434 |
| Surgeon General Report | 0.371012 |
| bajo contenido | 0.394946 |
| numerosos estudios | 0.665863 |
| Women’s Health Study | 0.359964 |
| principal factor | 0.344815 |
| verdadera relación causa-efecto | 0.391629 |
| Beta-Carotene Cancer Prevention | 0.361998 |
| altas concentraciones | 0.445954 |
|
| childhood cancer | 0.413412 |
| radón causa | 0.381229 |
| hombres finlandeses fumadores | 0.435889 |
| Multi-Ethnic Cohort Study | 0.379617 |
| Subsequent neoplasms | 0.341756 |
| tabaco causa | 0.392636 |
| alta prevalencia | 0.370255 |
| múltiples lesiones | 0.390734 |
| elementos carcinógenos | 0.375898 |
| Health Study | 0.393239 |
| actividad fÃsica protegen | 0.368641 |
| Data Monitoring Committee | 0.35531 |
| Heart Protection Study | 0.358634 |
| paciente fumador | 0.3962 |
| antecedentes familiares | 0.486318 |
| Cancer Prevention Study | 0.381093 |
| gas radón | 0.368394 |
| principal causa | 0.345807 |
| pacientes fumadores | 0.416554 |
| Cancer Survivor Study | 0.382901 |
| múltiples lesiones premalignas | 0.362501 |
| mayores incrementos | 0.341189 |
| Cancer Prevention | 0.39737 |
| HOPE-The Ongoing Outcomes | 0.356111 |
|
CLICK HERE |
| 2973 |
National Cancer Institute |
Video |
en |
Make Sure You Have What It Takes |
Ready to quit smoking? Make sure you have what it takes. Visit teen.smokefree.gov. |
| 02 | 0.414634 |
| ElixirMediaProd | 0.414568 |
| CDC | 0.732439 |
| QuitSmokingCom | 0.418054 |
| Sperm | 0.414461 |
| Famous People | 0.497717 |
| body | 0.415775 |
| Anti Smoking Commercial | 0.594002 |
| Disease Control | 0.79595 |
| Michael | 0.432529 |
| List | 0.414915 |
| Belhus | 0.420781 |
| Story | 0.414456 |
| Ellie | 0.41667 |
| Smokers | 0.569726 |
| Asthma Attack | 0.474832 |
| Duration | 0.939681 |
| Home Alchemy | 0.475983 |
| Hollywood | 0.417592 |
| mutation | 0.414755 |
| Smoking Advice | 0.525781 |
| Men | 0.414403 |
| Unattractive Things | 0.479984 |
| basement | 0.414589 |
|
| Smoking Timeline | 0.544895 |
| Centers | 0.483728 |
| NHS Smokefree | 0.484439 |
| Allen Carr | 0.481427 |
| Unkle Adams | 0.494687 |
| Losers Game | 0.480152 |
| air | 0.41576 |
| Aadarsh Sharma | 0.493771 |
| Videos | 0.414563 |
| Prevention | 0.483581 |
| Chicken Egg | 0.47424 |
| Great Ads | 0.480844 |
| smoking | 0.667373 |
| Smoking PSA | 0.536443 |
| views | 0.800457 |
| Terrifying | 0.418131 |
| CDC Tips | 0.549794 |
| James | 0.414466 |
| Domonic Smith | 0.486979 |
| Quit Smoking | 0.543911 |
| COPD patient | 0.483677 |
| Olly | 0.42117 |
| Planet Nibiru | 0.480348 |
| Doritos Commercial Compilation | 0.548737 |
|
CLICK HERE |
| 3437 |
National Cancer Institute |
Html |
es |
Prevención del cáncer de estómago (gástrico) (PDQ®)–Versión para pacientes |
Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de estómago y sobre las investigaciones dirigidas a la prevención de esta enfermedad. |
| siguientes factores | 0.837019 |
| voluntarios sanos | 0.649737 |
| Physician Data Query | 0.828425 |
| siguientes afecciones | 0.700348 |
| Estados Unidos | 0.992286 |
| suficiente ejercicio | 0.665482 |
| prevención revisa | 0.656327 |
| PDQ Prevención | 0.701412 |
| bacteria helicobacter | 0.66365 |
|
| National Cancer Institute | 0.659684 |
| vitamina c | 0.655742 |
| tipo a | 0.654153 |
| siguientes riesgos | 0.647812 |
| alto contenido | 0.74292 |
| siguientes sumarios | 0.735961 |
| vitamina b12 | 0.670397 |
| Instituto Nacional | 0.708301 |
|
CLICK HERE |
| 3561 |
National Cancer Institute |
Html |
en |
Obesity |
People who are obese may have an increased risk of several types of cancer, whereas eating a healthy diet, being physically active, and keeping a healthy weight may help reduce risk of some cancers. |
| National Heart | 0.499901 |
| Obesity | 0.347906 |
| healthy diet | 0.745052 |
| gallbladder | 0.258317 |
| healthy behaviors | 0.755955 |
| Cancer fact sheets | 0.830969 |
| healthy weight | 0.977177 |
| Physical Activity | 0.512739 |
| Overweight | 0.225819 |
| Blood Institute | 0.497718 |
| kidney | 0.214739 |
|
| uterus | 0.266957 |
| menopause | 0.223953 |
| high blood pressure | 0.86289 |
| heart disease | 0.510853 |
| pancreas | 0.241431 |
| cancers | 0.402713 |
| colon | 0.229687 |
| risk | 0.325352 |
| rectum | 0.279116 |
| information | 0.236001 |
|
CLICK HERE |
| 4389 |
National Cancer Institute |
Html |
en |
Sunlight |
Exposure to UV radiation from the sun, sunlamps, and tanning booths causes early aging and skin damage that can lead to skin cancer. Find information, including tips, on how to protect your skin. |
| skin cancer | 0.670141 |
| sun visors | 0.456822 |
| shades | 0.330644 |
| early aging | 0.476035 |
| dark skin | 0.458278 |
| sources | 0.329654 |
| skin damage | 0.480277 |
| wide brim | 0.466856 |
| windshields | 0.391235 |
| mid-morning | 0.329734 |
| long pants | 0.452301 |
| skin | 0.754109 |
| SPF | 0.373931 |
| ice | 0.356895 |
| UPF | 0.341366 |
| clouds | 0.329163 |
| skin tones | 0.597399 |
| tips | 0.329364 |
| Wear sunglasses | 0.448638 |
| sun protection factor | 0.555629 |
| dark fabrics | 0.445529 |
| light skin tone | 0.592307 |
| hat | 0.32822 |
|
| pavement | 0.327954 |
| mind | 0.357411 |
| late afternoon | 0.469796 |
| light clothing | 0.439637 |
| Exposure | 0.331467 |
| sunscreen products | 0.456996 |
| windows | 0.357118 |
| neck | 0.328307 |
| people | 0.384721 |
| water | 0.356986 |
| UV radiation | 0.940101 |
| sand | 0.362057 |
| sunlight | 0.380409 |
| ultraviolet protection factor | 0.576115 |
| snow | 0.359149 |
| booths | 0.335732 |
| parts | 0.327951 |
| ages | 0.329914 |
| sunlamps | 0.332236 |
| time | 0.329824 |
| beds | 0.330757 |
| rays | 0.330102 |
|
CLICK HERE |
| 15638 |
National Cancer Institute |
Html |
null |
Cooperative Agreements |
null |
|
|
CLICK HERE |
| 16847 |
National Cancer Institute |
Html |
en |
Safety of Nanotechnology Cancer Treatment |
Nanotechnology is a powerful tool for combating cancer. NCI's Alliance for Nanotechnology in Cancer is continuously testing the safety of this new technology. |
| nanotech applications | 0.677357 |
| animal models | 0.640611 |
| new technology | 0.654112 |
| tissue damage | 0.64104 |
| cancer therapy | 0.659011 |
| ambient incidental nanoparticles | 0.981236 |
| high reactivity | 0.657801 |
| energy consumption | 0.667996 |
| volcanic ash | 0.655357 |
| small size | 0.652566 |
| nanomaterial safety | 0.671123 |
| NCL works | 0.785834 |
| greenhouse gas emissions | 0.807194 |
| nanomaterials | 0.638465 |
| potential health risks | 0.757642 |
| potential toxicity | 0.657709 |
| industrial applications—have | 0.651915 |
| voluntary-consensus standards | 0.640352 |
| powerful tool | 0.664491 |
| physicochemical properties | 0.648003 |
| available data | 0.647533 |
| NCL | 0.841511 |
| NCL tests | 0.795621 |
| unresolved debate | 0.653791 |
| unique tensile | 0.653407 |
|
| specific type | 0.6502 |
| over-the-counter dandruff remedies | 0.781003 |
| drug carriers | 0.640153 |
| potential risks | 0.643319 |
| Nanotechnology Characterization Laboratory | 0.835959 |
| different nanoparticles | 0.793593 |
| NCI Alliance | 0.651255 |
| order-of-magnitude higher levels | 0.778354 |
| nanoparticle exposure studies | 0.785887 |
| intramural program | 0.646486 |
| background incidental nanoparticles | 0.982807 |
| Stone Age | 0.656862 |
| nanomaterial—carbon nanotubes | 0.650728 |
| cancer applications | 0.701263 |
| human activities | 0.656976 |
| household cleaning products | 0.76545 |
| sea spray | 0.653365 |
| animal studies | 0.647308 |
| cancer research communities | 0.992223 |
| toxicity testing | 0.646545 |
| nanomaterial types | 0.658682 |
| medical applications | 0.642559 |
| magnetic properties | 0.653737 |
| family pets | 0.646993 |
|
CLICK HERE |